Rabeprazole Sodium Hydrate is a proton pump inhibitor belonging to the benzimidazole class, used clinically to treat conditions associated with excessive gastric acid secretion such as gastroesophageal… Read more
Rabeprazole Sodium Hydrate is a proton pump inhibitor belonging to the benzimidazole class, used clinically to treat conditions associated with excessive gastric acid secretion such as gastroesophageal reflux disease and Zollinger-Ellison syndrome. Pharmaceutical laboratories utilize this reference standard along with its associated degradation products, metabolites, and stable isotope-labelled compounds to ensure rigorous quality control and method validation during pharmaceutical development. By providing essential material for assay development and impurity profiling, these compounds allow chemists to accurately identify and quantify potential impurities, including both pharmacopeial and non-pharmacopeial species, in generic and innovator formulations. Incorporating high-quality reference standards and isotopically labelled internal standards into analytical workflows remains vital for verifying the safety and efficacy of therapeutic products throughout their lifecycle.